Paragon Care Limited (FRA:PXS)

Market Cap	204.62M -58.6%
Revenue (ttm)	2.02B +21.7%
Net Income	11.49M +151.5%
EPS	0.01 +42.5%
Shares Out	n/a
PE Ratio	17.82
Forward PE	10.15
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.1150
Previous Close	0.1190
Day's Range	0.1150 - 0.1150
52-Week Range	0.1000 - 0.3240
Beta	n/a
RSI	44.08
Earnings Date	Feb 24, 2026

About Paragon Care

Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provides neonatal and paediatric assessment, including newborn hearing and vision screening, jaundice management, NICU video monitoring, brain monitoring, b...

• Industry: Specialty Cleaning, Polishing, and Sanitation Preparations
• CEO: Carmen Riley
• Employees: 550
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PXS

Financial Performance

In fiscal year 2025, Paragon Care's revenue was 3.61 billion, an increase of 21.68% compared to the previous year's 2.97 billion. Earnings were 20.57 million, an increase of 151.52%.

Financial numbers in AUD